A HER‐2‐positive result requires the demonstration of HER‐2 protein overexpression (3+ staining by IHC) or HER‐2 gene amplification by FISH.8, 9 The accurate identification of HER‐2 status is critical to the appropriate management of breast cancer patients. Here, ERBB2 is linked to breast carcinoma.